- Home
- CZNC vs CADL Comparison
CZNC vs CADL Comparison
Compare CZNC & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZNC
- CADL
- Stock Information
- Founded
- CZNC 1864
- CADL 1999
- Country
- CZNC United States
- CADL United States
- Employees
- CZNC N/A
- CADL N/A
- Industry
- CZNC Major Banks
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- CZNC Finance
- CADL Health Care
- Exchange
- CZNC Nasdaq
- CADL Nasdaq
- Market Cap
- CZNC 297.0M
- CADL 315.1M
- IPO Year
- CZNC N/A
- CADL 2021
- Fundamental
- Price
- CZNC $18.69
- CADL $6.02
- Analyst Decision
- CZNC
- CADL Strong Buy
- Analyst Count
- CZNC 0
- CADL 5
- Target Price
- CZNC N/A
- CADL $21.40
- AVG Volume (30 Days)
- CZNC 44.8K
- CADL 815.0K
- Earning Date
- CZNC 08-15-2025
- CADL 08-19-2025
- Dividend Yield
- CZNC 5.99%
- CADL N/A
- EPS Growth
- CZNC 15.59
- CADL N/A
- EPS
- CZNC 1.75
- CADL N/A
- Revenue
- CZNC $108,310,000.00
- CADL N/A
- Revenue This Year
- CZNC $5.72
- CADL N/A
- Revenue Next Year
- CZNC $7.18
- CADL N/A
- P/E Ratio
- CZNC $10.71
- CADL N/A
- Revenue Growth
- CZNC 4.96
- CADL N/A
- 52 Week Low
- CZNC $17.85
- CADL $3.79
- 52 Week High
- CZNC $22.68
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- CZNC 43.87
- CADL 46.67
- Support Level
- CZNC $18.16
- CADL $5.74
- Resistance Level
- CZNC $19.10
- CADL $6.40
- Average True Range (ATR)
- CZNC 0.46
- CADL 0.34
- MACD
- CZNC -0.10
- CADL -0.14
- Stochastic Oscillator
- CZNC 28.96
- CADL 19.05
About CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.